RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Essentials of RA: Regulatory Intelligence Tools Update 2008: Drugs and Biologics

Essentials of RA: Regulatory Intelligence Tools Update 2008: Drugs and Biologics

Posted 01 August 2008 | By

Regulatory Intelligence has been defined by US Ring (A Drug Information Association special interest area community) as:

"The act of gathering and analyzing publicly available regulatory information. This includes communicating the implications of that information, and monitoring the current regulatory environment for opportunities to shape future regulations, guidance, policy, and legislation."

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.